microRNA-22 Inhibition Stimulates Mitochondrial Homeostasis and Intracellular Degradation Pathways to Prevent Muscle...

Area of Science:

• Biochemistry
• Molecular Biology
• Muscle Physiology

Background:

• MicroRNA-22 (miR-22) negatively regulates mitochondrial biogenesis and metabolism in active tissues.
• Obesity and metabolic syndrome are linked to impaired metabolic flexibility and muscle mass loss due to ectopic fat accumulation.
• Intramuscular fat and poor mitochondrial function characterize muscle atrophy in obesity and neuromuscular disorders like Duchenne muscular dystrophy.

Purpose of the Study:

• To investigate the potential of inhibiting miR-22 as a therapeutic strategy for muscle health.
• To evaluate the efficacy of an antisense oligonucleotide (ASO) targeting miR-22 in preclinical models of muscle wasting.

Main Methods:

• Developed a mixmer antisense oligonucleotide (ASO) targeting miR-22 (anti-miR-22).
• Administered anti-miR-22 in mouse models of obesity and Duchenne muscular dystrophy.
• Assessed effects on myogenesis, muscle function, fatigue resistance, fibrosis, mitochondrial homeostasis, and autophagy.

Main Results:

• Anti-miR-22 treatment improved myogenesis in obese mice and protected dystrophic mice from muscle decline.
• The treatment enhanced fatigue resistance and reduced pathological fibrosis in both models.
• Mechanistically, anti-miR-22 promoted mitochondrial homeostasis, increased oxidative fiber content, and enhanced autophagy via mTOR signaling inhibition.

Conclusions:

• miR-22 is a viable molecular target for improving muscle health in various muscle-wasting conditions.
• Pharmacological inhibition of miR-22 with ASOs offers a promising therapeutic avenue for muscle atrophy.
• This strategy restores metabolic capacity and promotes a more resilient muscle phenotype.